Skip to main content
Clinical Trials/JPRN-jRCTs052220034
JPRN-jRCTs052220034
Active, not recruiting
Phase 3

Effect of NoL -Directed Analgesic management on opioid usage in Robot-assisted laparoscopic radical prostatectomy - a Randomized Controlled Trial - (NOLDOR study) - NOLDOR study

Tanaka Nobuhiro0 sites54 target enrollmentMay 27, 2022
ConditionsProstate cancer

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Prostate cancer
Sponsor
Tanaka Nobuhiro
Enrollment
54
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 27, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Tanaka Nobuhiro

Eligibility Criteria

Inclusion Criteria

  • 1\) Male patients undergoing scheduled robot\-assisted laparoscopic radical prostatectomy
  • 2\) Patients who were classed as American societyof anesthesiologists performance status (ASA\-PS)
  • 3\) Patients aged between 20 and 85 years old
  • 4\) Patients who have given written consent to participate in the study

Exclusion Criteria

  • 1\) Patients undergoing emergency surgery applied for the day
  • 2\) Patients taking beta\-blockers, or applying patches for this drug
  • 3\) Patients taking oral steroids
  • 4\) Patients who cannot secure the measurement site due to a amputation of the finger or lesion on
  • 5\) Patients with inability to give consent
  • 6\) Patients who have been judged inappropriate in the study by the investigator or sub\-investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials